Slingshot members are tracking this event:

FibroGen safety portion of roxadustat Phase 3 program in line for completion in second quarter 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
FGEN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 31, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Safety Data, Roxadustat, Phase 3